Sign in

CIK 0001850902

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Alpha Teknova, Inc.

Sign in to watch
Ticker
TKNO
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943368109
Phone
+1 831-637-1100
Business address
2451 BERT DRIVE, HOLLISTER, CA, 95023
  1. 4 Open-market buy President and CEO bought 80,645 shares at $1.24 ($100,000)
  2. 4 Grant or award Director acquired 20,000 shares (grant or award)
  3. 4 Grant or award Director acquired 20,000 shares (grant or award)
  4. 4 Grant or award Director acquired 20,000 shares (grant or award)
  5. 4 Open-market buy Director bought 9,212 shares at an average $5.37 ($49,504)
  6. 4 Grant or award Director acquired 18,815 shares (grant or award)
  7. 4 Grant or award Director acquired 18,815 shares (grant or award)
  8. 4 Grant or award Director acquired 18,815 shares (grant or award)
  9. 4 Open-market buy Chief Commercial Officer bought 3,587 shares at $1.73 ($6,220)
  10. 4 Other disposition Chief People Officer disposed of 15,000 shares (other)
  11. 4 Open-market buy 10% owner bought 8,108,107 shares at $1.85 ($14,999,998)
  12. 4 Open-market buy General Counsel and CCO bought 27,027 shares at $1.85 ($50,000)
  13. 4 Open-market buy Director bought 810,810 shares at $1.85 ($1,499,999)
  14. 4 Open-market buy Chief Financial Officer bought 54,054 shares at $1.85 ($100,000)
  15. 4 Open-market buy President and CEO bought 54,054 shares at $1.85 ($100,000)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale Chief People Officer sold 11,400 shares at $3.80 ($43,268)
  19. 4 Open-market buy Director bought 2,000 shares at an average $3.22 ($6,430)
  20. 4 Open-market buy Director bought 2,000 shares at an average $3.22 ($6,430)

Page 2 of 5 · 93 filings